Zee Files $8 Million Suit In ICC TV Rights Dispute With Star India
Zee Entertainment Enterprises Ltd. has counter claimed $8.06 million plus interest from Star India Pvt. Ltd. in a broadcasting rights dispute for International Cricket Council's men's tournaments over four years.
As per Zee's regulatory filing from Thursday, the two entities had entered into an alliance agreement in August 2022 regarding the ICC rights. However, on Sept. 16, 2024, Star had claimed damages of $940 million, along with costs, expenses and applicable interest until full payment from Zee in the statement of case filed before the London Court of International Arbitration.
The management, based on a legal opinion and its internal assessment, has determined that the company is not in default of the Alliance Agreement and believes that the claims made by Star are unfounded and legally not tenable, the exchange filing said.
As per the deal, Zee had to come out with financial commitments such as a bank guarantee and corporate guarantees and the company was also anticipating a major media expansion.
However, it is Star's submission that Zee could not fulfil the first installment of $203.56 million as per the agreed terms. This pertains to rights fee and other payments for bank guarantee commissions. Star has claimed that this failure constitutes default on agreement terms.
On June 20, 2024, Star terminated the agreement. Subsequently, Star started arbitration proceedings at the London Court of International Arbitration.
A statement of defence was filed by Zee on Dec. 23, 2024 submitting that all claims of default made by Star are unsubstantiated.
The outcome of the arbitral tribunal is yet to be determined.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.